In the FACT cohort, multivariable logistic regressions adjusted for atrial fibrillation, history of smoking, rheumatic disease and treatment for dyslipidemia, elevated levels of IL-17 (p = 0.007) and IL-18 (p = 0.003) were predictors of ACS. Here, IL17A is linked to metabolic syndrome.